Skip to main content
Top
Published in: Journal of Inflammation 1/2008

Open Access 01-12-2008 | Research

Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression

Authors: Michael Eberlein, Kara A Scheibner, Katharine E Black, Samuel L Collins, Yee Chan-Li, Jonathan D Powell, Maureen R Horton

Published in: Journal of Inflammation | Issue 1/2008

Login to get access

Abstract

Background

The balance between reactive oxygen species (ROS) and endogenous anti-oxidants is important in maintaining healthy tissues. Excessive ROS states occur in diseases such as ARDS and Idiopathic Pulmonary Fibrosis. Redox imbalance breaks down the extracellular matrix component hyaluronan (HA) into fragments that activate innate immune responses and perpetuate tissue injury. HA fragments, via a TLR and NF-κB pathway, induce inflammatory gene expression in macrophages and epithelial cells. NAC and DMSO are potent anti-oxidants which may help balance excess ROS states.

Methods

We evaluated the effect of H2O2, NAC and DMSO on HA fragment induced inflammatory gene expression in alveolar macrophages and epithelial cells.

Results

NAC and DMSO inhibit HA fragment-induced expression of TNF-α and KC protein in alveolar and peritoneal macrophages. NAC and DMSO also show a dose dependent inhibition of IP-10 protein expression, but not IL-8 protein, in alveolar epithelial cells. In addition, H2O2 synergizes with HA fragments to induce inflammatory genes, which are inhibited by NAC. Mechanistically, NAC and DMSO inhibit HA induced gene expression by inhibiting NF-κB activation, but NAC had no influence on HA-fragment-AP-1 mediated gene expression.

Conclusion

ROS play a central role in a pathophysiologic "vicious cycle" of inflammation: tissue injury generates ROS, which fragment the extracellular matrix HA, which in turn synergize with ROS to activate the innate immune system and further promote ROS, HA fragment generation, inflammation, tissue injury and ultimately fibrosis. The anti-oxidants NAC and DMSO, by inhibiting the HA induced inflammatory gene expression, may help re-balance excessive ROS induced inflammation.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gutteridge JM, M J: Redox imbalance in the critically ill. Br Med Bull. 1999, 55: 49-75. 10.1258/0007142991902295.PubMedCrossRef Gutteridge JM, M J: Redox imbalance in the critically ill. Br Med Bull. 1999, 55: 49-75. 10.1258/0007142991902295.PubMedCrossRef
2.
go back to reference Gloire GL-PS, Piette J: NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol. 2006, 72: 1493-1505. 10.1016/j.bcp.2006.04.011.PubMedCrossRef Gloire GL-PS, Piette J: NF-kappaB activation by reactive oxygen species: fifteen years later. Biochem Pharmacol. 2006, 72: 1493-1505. 10.1016/j.bcp.2006.04.011.PubMedCrossRef
3.
go back to reference Cross CE, vd VA, O'Neill CA, Eiserich JP: Reactive oxygen species and the lung. Lancet. 1994, 344: 930-933. 10.1016/S0140-6736(94)92275-6.PubMedCrossRef Cross CE, vd VA, O'Neill CA, Eiserich JP: Reactive oxygen species and the lung. Lancet. 1994, 344: 930-933. 10.1016/S0140-6736(94)92275-6.PubMedCrossRef
5.
go back to reference Gao F, Kinnula VL, Myllarniemi M, Oury TD: Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal. 2008, 10: 343-354. 10.1089/ars.2007.1908.PubMedPubMedCentralCrossRef Gao F, Kinnula VL, Myllarniemi M, Oury TD: Extracellular superoxide dismutase in pulmonary fibrosis. Antioxid Redox Signal. 2008, 10: 343-354. 10.1089/ars.2007.1908.PubMedPubMedCentralCrossRef
6.
go back to reference Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, et al: High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005, 353: 2229-2242. 10.1056/NEJMoa042976.PubMedCrossRef Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, et al: High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med. 2005, 353: 2229-2242. 10.1056/NEJMoa042976.PubMedCrossRef
7.
9.
go back to reference Saari H, Konttinen YT, Friman C, Sorsa T: Differential effects of reactive oxygen species on native synovial fluid and purified human umbilical cord hyaluronate. Inflammation. 1993, 17: 403-415. 10.1007/BF00916581.PubMedCrossRef Saari H, Konttinen YT, Friman C, Sorsa T: Differential effects of reactive oxygen species on native synovial fluid and purified human umbilical cord hyaluronate. Inflammation. 1993, 17: 403-415. 10.1007/BF00916581.PubMedCrossRef
10.
11.
go back to reference Laurent TC: Functions of Hyaluronan. A Rheum Dis. 1995, 54: 429-10.1136/ard.54.5.429.CrossRef Laurent TC: Functions of Hyaluronan. A Rheum Dis. 1995, 54: 429-10.1136/ard.54.5.429.CrossRef
12.
go back to reference Hance AJ, Crystal RG: The connective tissue of lung. Am Rev Resp Dis. 1975, 112: 657-668.PubMed Hance AJ, Crystal RG: The connective tissue of lung. Am Rev Resp Dis. 1975, 112: 657-668.PubMed
13.
go back to reference Laurent TC, Fraser JR, Laurent UB, Engstrom-Laurent A: Hyaluronan in inflammatory joint disease. Acta Orthop Scand Suppl. 1995, 266: 116-120.PubMed Laurent TC, Fraser JR, Laurent UB, Engstrom-Laurent A: Hyaluronan in inflammatory joint disease. Acta Orthop Scand Suppl. 1995, 266: 116-120.PubMed
14.
go back to reference Bjermer L, Eklund A, Blaschke E: Bronchoalveolar lavage fibronectin in patients with sarcoidosis: correlation to hyaluronan and disease activity. Eur Resp J. 1991, 4: 965-971. Bjermer L, Eklund A, Blaschke E: Bronchoalveolar lavage fibronectin in patients with sarcoidosis: correlation to hyaluronan and disease activity. Eur Resp J. 1991, 4: 965-971.
15.
go back to reference Hallgren R, Eklund A, Engstrom-Laurent B, Schmekel B: Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Brit Med J. 1985, 290: 1778-1781.CrossRef Hallgren R, Eklund A, Engstrom-Laurent B, Schmekel B: Hyaluronate in bronchoalveolar lavage fluid: a new marker in sarcoidosis reflecting pulmonary disease. Brit Med J. 1985, 290: 1778-1781.CrossRef
16.
go back to reference Riise GC, A S, Larsson S, Enander I, Jones I, Larsson P, Andersson B: Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax. 1995, 50: 360-365. 10.1136/thx.50.4.360.PubMedPubMedCentralCrossRef Riise GC, A S, Larsson S, Enander I, Jones I, Larsson P, Andersson B: Bronchial inflammation in chronic bronchitis assessed by measurement of cell products in bronchial lavage fluid. Thorax. 1995, 50: 360-365. 10.1136/thx.50.4.360.PubMedPubMedCentralCrossRef
17.
go back to reference Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, et al: Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005, 11: 1173-1179. 10.1038/nm1315.PubMedCrossRef Jiang D, Liang J, Fan J, Yu S, Chen S, Luo Y, Prestwich GD, Mascarenhas MM, Garg HG, Quinn DA, et al: Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005, 11: 1173-1179. 10.1038/nm1315.PubMedCrossRef
18.
go back to reference Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW: Resolution of lung inflammation by CD44. Science. 2002, 296: 155-158. 10.1126/science.1069659.PubMedCrossRef Teder P, Vandivier RW, Jiang D, Liang J, Cohn L, Pure E, Henson PM, Noble PW: Resolution of lung inflammation by CD44. Science. 2002, 296: 155-158. 10.1126/science.1069659.PubMedCrossRef
19.
go back to reference Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR: Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol. 2006, 177: 1272-1281.PubMedCrossRef Scheibner KA, Lutz MA, Boodoo S, Fenton MJ, Powell JD, Horton MR: Hyaluronan fragments act as an endogenous danger signal by engaging TLR2. J Immunol. 2006, 177: 1272-1281.PubMedCrossRef
20.
go back to reference Hodge-Dufour J, Marino MW, Horton MR, Jungbluth A, Burdick MD, Strieter RM, Noble PW, Hunter CA, Pure E: Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci USA. 1998, 95: 13806-13811. 10.1073/pnas.95.23.13806.PubMedPubMedCentralCrossRef Hodge-Dufour J, Marino MW, Horton MR, Jungbluth A, Burdick MD, Strieter RM, Noble PW, Hunter CA, Pure E: Inhibition of interferon gamma induced interleukin 12 production: a potential mechanism for the anti-inflammatory activities of tumor necrosis factor. Proc Natl Acad Sci USA. 1998, 95: 13806-13811. 10.1073/pnas.95.23.13806.PubMedPubMedCentralCrossRef
21.
go back to reference Horton MR, Burdick MD, Strieter RM, Bao C, Noble PW: Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. J Immunol. 1998, 160: 3023-3030.PubMed Horton MR, Burdick MD, Strieter RM, Bao C, Noble PW: Regulation of hyaluronan-induced chemokine gene expression by IL-10 and IFN-gamma in mouse macrophages. J Immunol. 1998, 160: 3023-3030.PubMed
22.
go back to reference Horton MR, McKee CM, Bao C, Liao F, Farber JM, Hodge-DuFour J, Pure E, Oliver BL, Wright TM, Noble PW: Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem. 1998, 52: 35088-35094. 10.1074/jbc.273.52.35088.CrossRef Horton MR, McKee CM, Bao C, Liao F, Farber JM, Hodge-DuFour J, Pure E, Oliver BL, Wright TM, Noble PW: Hyaluronan fragments synergize with interferon-gamma to induce the C-X-C chemokines mig and interferon-inducible protein-10 in mouse macrophages. J Biol Chem. 1998, 52: 35088-35094. 10.1074/jbc.273.52.35088.CrossRef
23.
go back to reference Horton MR, Olman MA, Bao C, White KE, Choi AM, Chin BY, Noble PW, Lowenstein CJ: Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol. 2000, 279: L707-715.PubMed Horton MR, Olman MA, Bao C, White KE, Choi AM, Chin BY, Noble PW, Lowenstein CJ: Regulation of plasminogen activator inhibitor-1 and urokinase by hyaluronan fragments in mouse macrophages. Am J Physiol Lung Cell Mol Physiol. 2000, 279: L707-715.PubMed
24.
go back to reference Horton MR, Shapiro S, Bao C, Lowenstein CJ, Noble PW: Induction and regulation of macrophage metalloelastase by Hyaluronan fragments in mouse macrophages. J Immunol. 1999, 4171-4176. Horton MR, Shapiro S, Bao C, Lowenstein CJ, Noble PW: Induction and regulation of macrophage metalloelastase by Hyaluronan fragments in mouse macrophages. J Immunol. 1999, 4171-4176.
25.
go back to reference McKee C, Penno M, Cowman M, Burdick M, Strieter R, Bao C, Noble P: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest. 1996, 98: 2403-2413. 10.1172/JCI119054.PubMedPubMedCentralCrossRef McKee C, Penno M, Cowman M, Burdick M, Strieter R, Bao C, Noble P: Hyaluronan (HA) fragments induce chemokine gene expression in alveolar macrophages. The role of HA size and CD44. J Clin Invest. 1996, 98: 2403-2413. 10.1172/JCI119054.PubMedPubMedCentralCrossRef
26.
go back to reference Paterson RL, G H, Webster NR: The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003, 31: 2574-2578. 10.1097/01.CCM.0000089945.69588.18.PubMedCrossRef Paterson RL, G H, Webster NR: The effect of N-acetylcysteine on nuclear factor-kappa B activation, interleukin-6, interleukin-8, and intercellular adhesion molecule-1 expression in patients with sepsis. Crit Care Med. 2003, 31: 2574-2578. 10.1097/01.CCM.0000089945.69588.18.PubMedCrossRef
27.
go back to reference Pepin JMLR: Effects of dimethyl sulfoxide (DMSO) on bleomycin-induced pulmonary fibrosis. Biochem Pharmacol. 1985, 34: 2386-2389. 10.1016/0006-2952(85)90799-3.PubMedCrossRef Pepin JMLR: Effects of dimethyl sulfoxide (DMSO) on bleomycin-induced pulmonary fibrosis. Biochem Pharmacol. 1985, 34: 2386-2389. 10.1016/0006-2952(85)90799-3.PubMedCrossRef
28.
go back to reference Mata M, Ruiz A, Cerda M, Martinez-Losa M, Cortijo J, Santangelo F, Serrano-Mollar A, Llombart-Bosch A, Morcillo EJ: Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Respir J. 2003, 22: 900-905. 10.1183/09031936.03.00018003.PubMedCrossRef Mata M, Ruiz A, Cerda M, Martinez-Losa M, Cortijo J, Santangelo F, Serrano-Mollar A, Llombart-Bosch A, Morcillo EJ: Oral N-acetylcysteine reduces bleomycin-induced lung damage and mucin Muc5ac expression in rats. Eur Respir J. 2003, 22: 900-905. 10.1183/09031936.03.00018003.PubMedCrossRef
29.
go back to reference Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, Estrela JM, Morcillo EJ, Bulbena O: In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol. 2003, 138: 1037-1048. 10.1038/sj.bjp.0705138.PubMedPubMedCentralCrossRef Serrano-Mollar A, Closa D, Prats N, Blesa S, Martinez-Losa M, Cortijo J, Estrela JM, Morcillo EJ, Bulbena O: In vivo antioxidant treatment protects against bleomycin-induced lung damage in rats. Br J Pharmacol. 2003, 138: 1037-1048. 10.1038/sj.bjp.0705138.PubMedPubMedCentralCrossRef
30.
go back to reference Yildirim Z, Kotuk M, Iraz M, Kuku I, Ulu R, Armutcu F, Ozen S: Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine. Pulm Pharmacol Ther. 2005, 18: 367-373. 10.1016/j.pupt.2005.02.001.PubMedCrossRef Yildirim Z, Kotuk M, Iraz M, Kuku I, Ulu R, Armutcu F, Ozen S: Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine. Pulm Pharmacol Ther. 2005, 18: 367-373. 10.1016/j.pupt.2005.02.001.PubMedCrossRef
31.
go back to reference Haschek WM, Baer KE, Rutherford JE: Effects of dimethyl sulfoxide (DMSO) on pulmonary fibrosis in rats and mice. Toxicology. 1989, 54: 197-205. 10.1016/0300-483X(89)90045-0.PubMedCrossRef Haschek WM, Baer KE, Rutherford JE: Effects of dimethyl sulfoxide (DMSO) on pulmonary fibrosis in rats and mice. Toxicology. 1989, 54: 197-205. 10.1016/0300-483X(89)90045-0.PubMedCrossRef
32.
go back to reference Essani NA, F M, Jaeschke H: Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock. 1997, 17: 90-96.CrossRef Essani NA, F M, Jaeschke H: Inhibition of NF-kappa B activation by dimethyl sulfoxide correlates with suppression of TNF-alpha formation, reduced ICAM-1 gene transcription, and protection against endotoxin-induced liver injury. Shock. 1997, 17: 90-96.CrossRef
33.
go back to reference Boodoo S, Spannhake EW, Powell JD, Horton MR: Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006, 291: L479-486. 10.1152/ajplung.00518.2005.PubMedCrossRef Boodoo S, Spannhake EW, Powell JD, Horton MR: Differential regulation of hyaluronan-induced IL-8 and IP-10 in airway epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2006, 291: L479-486. 10.1152/ajplung.00518.2005.PubMedCrossRef
34.
go back to reference Kelly KA, Hill MR, Youkhana K, Wanker F, Gimble JM: Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages. Infect Immun. 1994, 62: 3122-3128.PubMedPubMedCentral Kelly KA, Hill MR, Youkhana K, Wanker F, Gimble JM: Dimethyl sulfoxide modulates NF-kappa B and cytokine activation in lipopolysaccharide-treated murine macrophages. Infect Immun. 1994, 62: 3122-3128.PubMedPubMedCentral
35.
go back to reference Fieber C, Baumann P, Vallon R, Termeer C, Simon JC, Hofmann M, Angel P, Herrlich P, Sleeman JP: Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci. 2004, 117: 359-367. 10.1242/jcs.00831.PubMedCrossRef Fieber C, Baumann P, Vallon R, Termeer C, Simon JC, Hofmann M, Angel P, Herrlich P, Sleeman JP: Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J Cell Sci. 2004, 117: 359-367. 10.1242/jcs.00831.PubMedCrossRef
36.
go back to reference Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC: Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002, 195: 99-111. 10.1084/jem.20001858.PubMedPubMedCentralCrossRef Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, Ahrens T, Miyake K, Freudenberg M, Galanos C, Simon JC: Oligosaccharides of Hyaluronan activate dendritic cells via toll-like receptor 4. J Exp Med. 2002, 195: 99-111. 10.1084/jem.20001858.PubMedPubMedCentralCrossRef
37.
go back to reference Piotrowski WJ, Marczak J: Cellular sources of oxidants in the lung. Int J Occup Med Environ Health. 2000, 13: 369-385.PubMed Piotrowski WJ, Marczak J: Cellular sources of oxidants in the lung. Int J Occup Med Environ Health. 2000, 13: 369-385.PubMed
38.
go back to reference Ndengele MM, M C, Wang ZQ, Doyle TM, Matuschak GM, Salvemini D: Superoxide potentiates NF-kappaB activation and modulates endotoxin-induced cytokine production in alveolar macrophages. Shock. 2005, 23: 186-193. 10.1097/01.shk.0000144130.36771.d6.PubMedCrossRef Ndengele MM, M C, Wang ZQ, Doyle TM, Matuschak GM, Salvemini D: Superoxide potentiates NF-kappaB activation and modulates endotoxin-induced cytokine production in alveolar macrophages. Shock. 2005, 23: 186-193. 10.1097/01.shk.0000144130.36771.d6.PubMedCrossRef
39.
go back to reference Sanlioglu SWC, Samavati L, Butler NS, Wang G, McCray PB, Ritchie TC, H G, Zandi E, Engelhardt JF: Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem. 2001, 276: 30188-30198. 10.1074/jbc.M102061200.PubMedCrossRef Sanlioglu SWC, Samavati L, Butler NS, Wang G, McCray PB, Ritchie TC, H G, Zandi E, Engelhardt JF: Lipopolysaccharide induces Rac1-dependent reactive oxygen species formation and coordinates tumor necrosis factor-alpha secretion through IKK regulation of NF-kappa B. J Biol Chem. 2001, 276: 30188-30198. 10.1074/jbc.M102061200.PubMedCrossRef
40.
go back to reference Park HS, J H, Park EY, Kim J, Lee WJ, Bae YS: Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 2004, 173: 3589-3593.PubMedCrossRef Park HS, J H, Park EY, Kim J, Lee WJ, Bae YS: Cutting edge: direct interaction of TLR4 with NAD(P)H oxidase 4 isozyme is essential for lipopolysaccharide-induced production of reactive oxygen species and activation of NF-kappa B. J Immunol. 2004, 173: 3589-3593.PubMedCrossRef
41.
go back to reference Pantano CRN, Vliet van der A, Janssen-Heininger YM: Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal. 2006, 8: 1791-1806. 10.1089/ars.2006.8.1791.PubMedCrossRef Pantano CRN, Vliet van der A, Janssen-Heininger YM: Redox-sensitive kinases of the nuclear factor-kappaB signaling pathway. Antioxid Redox Signal. 2006, 8: 1791-1806. 10.1089/ars.2006.8.1791.PubMedCrossRef
42.
go back to reference Forman HJ, T M: Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med. 2002, 166: S4-8. 10.1164/rccm.2206007.PubMedCrossRef Forman HJ, T M: Reactive oxygen species and cell signaling: respiratory burst in macrophage signaling. Am J Respir Crit Care Med. 2002, 166: S4-8. 10.1164/rccm.2206007.PubMedCrossRef
43.
go back to reference Noble PW, McKee CM, Cowman M, Shin HS: Hyaluronan fragments activate an NF-κB/IκBα autoregulatory loop in murine macrophages. J Exp Med. 1996, 183: 2373-2378. 10.1084/jem.183.5.2373.PubMedCrossRef Noble PW, McKee CM, Cowman M, Shin HS: Hyaluronan fragments activate an NF-κB/IκBα autoregulatory loop in murine macrophages. J Exp Med. 1996, 183: 2373-2378. 10.1084/jem.183.5.2373.PubMedCrossRef
44.
go back to reference Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med. 1992, 175: 1181-1194. 10.1084/jem.175.5.1181.PubMedCrossRef Schreck R, Meier B, Mannel DN, Droge W, Baeuerle PA: Dithiocarbamates as potent inhibitors of nuclear factor κB activation in intact cells. J Exp Med. 1992, 175: 1181-1194. 10.1084/jem.175.5.1181.PubMedCrossRef
45.
go back to reference Fattman CL, C L, Termin TA, Petersen L, Enghild JJ, Oury TD: Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med. 2003, 35: 763-771. 10.1016/S0891-5849(03)00402-7.PubMedCrossRef Fattman CL, C L, Termin TA, Petersen L, Enghild JJ, Oury TD: Enhanced bleomycin-induced pulmonary damage in mice lacking extracellular superoxide dismutase. Free Radic Biol Med. 2003, 35: 763-771. 10.1016/S0891-5849(03)00402-7.PubMedCrossRef
46.
go back to reference Inghilleri SMP, Oggionni T, Barni S, Fenoglio C: In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis. Histochem Cell Biol. 2006, 125: 661-669. 10.1007/s00418-005-0116-7.PubMedCrossRef Inghilleri SMP, Oggionni T, Barni S, Fenoglio C: In situ assessment of oxidant and nitrogenic stress in bleomycin pulmonary fibrosis. Histochem Cell Biol. 2006, 125: 661-669. 10.1007/s00418-005-0116-7.PubMedCrossRef
47.
go back to reference Manoury BNS, Leclerc O, Guenon I, Boichot E, Planquois JM, Bertrand CP, Lagente V: The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir Res. 2005, 6: 6-11. 10.1186/1465-9921-6-11.CrossRef Manoury BNS, Leclerc O, Guenon I, Boichot E, Planquois JM, Bertrand CP, Lagente V: The absence of reactive oxygen species production protects mice against bleomycin-induced pulmonary fibrosis. Respir Res. 2005, 6: 6-11. 10.1186/1465-9921-6-11.CrossRef
Metadata
Title
Anti-oxidant inhibition of hyaluronan fragment-induced inflammatory gene expression
Authors
Michael Eberlein
Kara A Scheibner
Katharine E Black
Samuel L Collins
Yee Chan-Li
Jonathan D Powell
Maureen R Horton
Publication date
01-12-2008
Publisher
BioMed Central
Published in
Journal of Inflammation / Issue 1/2008
Electronic ISSN: 1476-9255
DOI
https://doi.org/10.1186/1476-9255-5-20

Other articles of this Issue 1/2008

Journal of Inflammation 1/2008 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.